Mirion Technologies, Inc.

Greetings and welcome to the Miriam technology second quarter 2025 earnings conference call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce Eric Lynn, Vice President of Investor Relations. Please go ahead.

Thank you, Stacey. Good morning and welcome to Miriam second quarter 2025 earnings conference call. Joining me this morning are Miriam's Chairman and CEO Tom Logan and Miriam CFO and Medical Group President Brian Schopper. Before we begin today's prepared remarks, allow me to remind you that comments made during this call will include forward looking statements and actual results may differ materially from those projected in the forward looking statements. The factors that could cause actual results to differ are discussed in our annual report on form 10 K quarterly reports on form 10 Q and the Miriam's other SEC filings under the caption risk factors. Quarterly references within today's discussion are related to the second quarter and the June 30th 2025 unless otherwise noted. The comments made during this call will also include certain financial measures that were not prepared in accordance with generally accepted accounting principles. Reconciliation of those non gap financial measures to the most directly comparable gap financial measures can be found in the appendix of the presentation accompanying today's call. All earnings materials can be found in the investor relations section of our website at .miriam.com. With that, let me now turn the call over to Tom, who will begin on slide three.

Eric, thank you